Literature DB >> 16551445

Latent and potential celiac disease in epileptic Turkish children.

Buket Dalgiç1, Ismail Dursun, Ayşe Serdaroğlu, Ayşe Dursun.   

Abstract

In this study, we measured tissue transglutaminase IgA antibody for the serologic screening of celiac disease in 70 children with epilepsy. A pathologic titer of tissue transglutaminase IgA antibody was found in eight patients (4.7%). Small intestinal biopsies were performed in all antibody-positive patients, and two of them had small bowel histology typical of celiac disease (1.17%). Six had normal histology and were considered to have potential celiac disease. The prevalence of celiac disease in the epileptic group was 1.17%. None of the serum samples of 103 healthy children comprising the control group were positive for tissue transglutaminase IgA antibody. Therefore, we suggest that epileptic children be screened for celiac disease. (J Child Neurol 2006;21:6-7).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551445     DOI: 10.1177/08830738060210010301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

Review 1.  Extraintestinal manifestations of celiac disease.

Authors:  Lincoln Hernandez; Peter H Green
Journal:  Curr Gastroenterol Rep       Date:  2006-10

2.  Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-07-01

3.  Prevalence of celiac disease in Turkish children with idiopathic epilepsy.

Authors:  Sedat Işikay; Şamil Hizli; Kutluhan Yilmaz
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

4.  Clinical and Paraclinical Screening for Celiac Disease in Children with Intractable Epilepsy.

Authors:  Golnaz Ghazizadeh Esslami; Bahar Allahverdi; Reza Shervin Badv; Morteza Heidari; Nahid Khosroshahi; Hosein Shabani-Mirzaee; Kambiz Eftekhari
Journal:  Neurol Res Int       Date:  2021-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.